MYGN
Myriad Genetics Inc
4.10$
+3.2%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +2.4% | +2.8% | +4.6% | +0.9% | -1.3% | -7.0% | +8.8% | -3.5% | +2.0% | -4.5% | -4.8% | – | |
| – | +6.9% | +4.9% | -0.3% | -1.4% | -6.0% | +3.4% | -0.6% | +1.0% | +1.8% | -0.3% | +1.4% | – | |
| – | +0.5% | +1.9% | +6.9% | +1.8% | +0.7% | -11.1% | +13.1% | -5.3% | +2.1% | -6.3% | -7.7% | – | |
| – | -12.5% | +18.6% | +8.8% | +5.2% | +13.0% | -14.6% | -6.9% | +10.2% | -9.6% | +6.3% | -7.7% | – | |
| – | -76.0% | +118.4% | +1.3% | -4.0% | +114.0% | -55.1% | +0.5% | +1.6% | -18.1% | +11.9% | -7.1% | – | |
| – | -14.4% | -0.5% | +10.9% | -7.5% | +11.8% | -14.1% | +194.7% | -65.3% | -8.7% | +10.4% | -1.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -10.0% | -44.4% | +60.0% | +0.0% | -12.5% | +14.3% | +87.5% | +153.3% | +15.8% | -6.8% | +0.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -1,200.0% | – | -600.0% | – | +277.8% | -961.8% | – | – | -183.3% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | -316.0% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.